Cost-effectiveness analysis comparing in-office posterior nasal nerve ablation to surgical therapies.

ABSTRACT:

Background

Recently, in-office posterior nasal nerve ablation (PNA) devices have offered a new tool to treat refractory chronic rhinitis, but their cost-effectiveness relative to traditional interventions such as vidian neurectomy (VN) and posterior nasal neurectomy (PNN) remains unexplored.

Objective

To compare the cost-effectiveness of these interventions in patients with refractory chronic rhinitis.

Methods

A decision tree with embedded Markov models was created to compare the cost-effectiveness of PNN, VN, and PNA, measured in quality-adjusted life years (QALYs) over a 30-year time horizon with a $100,000/QALY willingness-to-pay threshold. One- and two-way sensitivity analyses were completed.

Results

Sensitivity analysis found that in-office PNA became cost

SUBMITTER: Saraswathula A 

PROVIDER: S-EPMC10033428 | biostudies-literature | 2023 Mar-Apr

REPOSITORIES: biostudies-literature